PARP-INHIBITORS CAN BE APPLIED TOGETHER WITH TUMOR TREATING FIELDS (TTFIELDS) TO PROLONG SURVIVAL IN AN OVARIAN CANCER MOUSE MODEL

被引:0
|
作者
Berckmans, Yani [1 ]
Wouters, Roxanne [1 ,2 ]
Thirion, Gitte [1 ]
Vandenbrande, Katja [1 ]
Vergote, Ignace [3 ]
Coosemans, An [1 ]
机构
[1] Lab Tumor Immunol & Immunotherapy, Leuven, Belgium
[2] Oncoinvent AS, Oslo, Norway
[3] Katholieke Univ Leuven, Div Gynaecol Oncol, UZ Leuven, Leuven, Belgium
关键词
D O I
10.1136/ijgc-2023-ESGO.585
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
471
引用
收藏
页码:A282 / A282
页数:1
相关论文
共 32 条
  • [31] Intraperitoneal delivery of a neoantigen surrogate by Listeria monocytogenes in combination with checkpoint inhibition reduced tumor burden and improved survival in an ovarian cancer mouse model
    Gabor, Lisa
    Khouri, Olivia
    Scanlon, Lauren
    Ahmad, Shahbaz
    Lin, Ken
    Kuo, Dennis Yi-Shin
    Gravekamp, Claudia
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S304 - S304
  • [32] Chimeric Antigen receptor-T (CAR-T) cells targeting Epithelial cell adhesion molecule (EpCAM) can inhibit tumor growth in ovarian cancer mouse model
    Fu, Juan
    Shang, Yuhong
    Qian, Zhang
    Hou, Jinping
    Yan, Feng
    Liu, Guodi
    Li Dehua
    Tian, Xiaoli
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2021, 83 (02): : 241 - 247